Evidence map›Paper›PMID 21490102›Full record

ArticleJournal of virology2011

Stimulation of homology-directed repair at I-SceI-induced DNA breaks during the permissive life cycle of human cytomegalovirus.

A S Kulkarni, E A Fortunato

Abstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Host DNA repair factors empower a mechanism of antiviral nucleoside analog resistance.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A S KulkarniDepartment of Biological Sciences and Center for Reproductive Biology, University of Idaho, Moscow, ID 83844-3051, USA.
E A Fortunato

Funding

TRANSCRIPTIONAL ATTENUATION OF THE TYPE I INTERFERON RESPONSE BY RHINOVIRUSP20RR015587 · NCRR · UNIVERSITY OF IDAHO · PI BOHACH, GREGORY A · 2000 to 2009
$19.0M
Repair of HCMV-Induced DNA Damage in Infected CellsR01AI051463 · NIAID · UNIVERSITY OF IDAHO · PI FORTUNATO, ELIZABETH A · 2003 to 2014
$2.7M
NCRR NIH HHS P20 RR015587NIAID NIH HHS R01 AI051463NIAID NIH HHS R01-AI51463
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) selectively relocalizes many DNA repair proteins, thereby avoiding a potentially detrimental damage response. In the present study, we evaluated interactions between HCMV and the homology-directed repair (HDR) pathway. In permissive human foreskin fibroblasts, a fluorescence-based double-stranded break repair assay was used to determine that HCMV stimulated HDR. Repair of both stably integrated and extrachromosomal reporter substrates was observed to increase. HDR was also stimulated through individual expression of the viral immediate-early protein IE1-72, mimicking full virus infection. These experiments further demonstrate HCMV's role in modulating critical cellular processes during a permissive infection.

Indexed as

DNA Breaks, Double-StrandedCell LineCytomegalovirusDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsDNA RepairFanconi Anemia Complementation Group G ProteinFibroblastsGreen Fluorescent ProteinsHumansImmediate-Early ProteinsRad51 RecombinaseVirus ReplicationDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsFANCG protein, humanFanconi Anemia Complementation Group G ProteinGreen Fluorescent ProteinsIE1 protein, cytomegalovirusImmediate-Early ProteinsRAD51C protein, humanRAD51 protein, humanRad51 Recombinase

Identifiers

PMID21490102
PMCPMC3126324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.